Comparison Tool

Select a country from the regions above then, add your country to our comparison tool to compare country specific information simultaneously across 3 countries

Japan


Fast Facts

  • Capital: Tokyo
  • Economy: 3rd largest economy in the world, nominal GDP US$4.6 trillion, 2014
  • Health Expenditure: 10.3% of GDP, 2013
  • Population: 127.13 million, 2014
  • Average Life Span: 81/87 (m/f), 2013
  • Languages: Variety of Japanese dialects
  • Adult Literacy Rate: 99% 2014

Health Trends

  • The health care system in Japan provides healthcare services, including screening examinations, prenatal care and infectious disease control, with the patient accepting responsibility for 30% of these costs while the government pays the remaining 70%. .
  • Payment for personal medical services offered through a universal health care insurance system that provides relative equality of access and fees set by government committee.
  • People without employers insurance can participate in a national health insurance program administered by local governments.
  • Since 1983, all elderly persons covered by government sponsored insurance.
  • Rates of lung cancer are very high: 496,000 men and 355,000 women developed cancer in 2011 in Japan. 
  • 7 million Japanese with diabetes which is expected to reach 10 million in the next ten years
  • Large group of ageing people. The aging of Japan outweighs all other nations with the highest proportion of elderly citizens, 21% over the age of 65
  • Japan is the second largest pharmaceutical market in the world and is expected to grow by 3% to 6% annually between 2010 and 2014. 
  • The top four causes of death in Japan are; cardiovascular disease, cancer, cerebrovascular disease and pneumonia.

Clinical Trial Landscape

  • 30 day regulatory review and approval for Clinical Trial Notification to PMDA.
  • Accepted the on-site IRB and the centralised IRB for the site.
  • National and University hospitals provide dedicated research teams across a variety of therapeutic areas.
  • Clinical Trial network e.g. National Hospital Organization network, spreads across large and medium cities.
  • Direct access to health care professionals.
  • Japanese Investigators regularly attend international conferences and are ICH/GCP and Japan/GCP compliant.
  • Good primary care network.
  • Sites deliver predicted patient numbers.
  • SMO is popular in Japan but is expensive.

.
 


ICON in Japan

Add to Comparison Tool
  • Presence in Japan since 1995
  • Experiencing strong growth in global trials
  • Several global oncology studies with outstanding enrolment dynamics
  • Japanese Website

Services Offered

  • Project Management and Clinical Operations (Phase II - III)
  • Medical & Safety Services
  • Medical Writing
  • Data Management
  • Regulatory Affairs 
  • Regulatory/Strategic Consultation
  • Phase l
  • Late Phase Research (Ph IV, PMS)
  • Central Laboratories Service
  • Imaging Service
  • Biostatistics
  • DOCS Resourcing Solutions:
    • Functional Resourcing 
    • Flexible Resourcing
    • Permanent Recruitment 

Contact Us for further information